[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT894010E - Desnaturantes para sais de amina simpaticomimetica - Google Patents

Desnaturantes para sais de amina simpaticomimetica

Info

Publication number
PT894010E
PT894010E PT97920079T PT97920079T PT894010E PT 894010 E PT894010 E PT 894010E PT 97920079 T PT97920079 T PT 97920079T PT 97920079 T PT97920079 T PT 97920079T PT 894010 E PT894010 E PT 894010E
Authority
PT
Portugal
Prior art keywords
sympathommomatic
desnaturants
amine salts
amine
salts
Prior art date
Application number
PT97920079T
Other languages
English (en)
Inventor
W Michael Nichols
William Bess
Stanley Lech
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PT894010E publication Critical patent/PT894010E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97920079T 1996-04-10 1997-04-01 Desnaturantes para sais de amina simpaticomimetica PT894010E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1523996P 1996-04-10 1996-04-10
US3260296P 1996-12-11 1996-12-11
US4055097P 1997-03-13 1997-03-13

Publications (1)

Publication Number Publication Date
PT894010E true PT894010E (pt) 2003-11-28

Family

ID=27360291

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97920079T PT894010E (pt) 1996-04-10 1997-04-01 Desnaturantes para sais de amina simpaticomimetica

Country Status (18)

Country Link
US (1) US6136864A (pt)
EP (1) EP0894010B1 (pt)
JP (1) JP2001527514A (pt)
AR (1) AR006571A1 (pt)
AT (1) ATE244019T1 (pt)
BR (1) BR9708559A (pt)
CA (1) CA2250010C (pt)
DE (1) DE69723248T2 (pt)
DK (1) DK0894010T3 (pt)
ES (1) ES2202605T3 (pt)
MX (1) MX9807594A (pt)
NZ (1) NZ332233A (pt)
PE (1) PE20011304A1 (pt)
PT (1) PT894010E (pt)
SI (1) SI0894010T1 (pt)
TW (1) TW522012B (pt)
UY (1) UY24512A1 (pt)
WO (1) WO1997037689A2 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
GT199900148A (es) 1998-09-10 2001-02-28 Desnaturalizantes para las sales aminas simpaticomimeticas.
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
JP4370451B2 (ja) * 2001-09-28 2009-11-25 大塚製薬株式会社 医薬組成物
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
LT1765292T (lt) 2004-06-12 2018-01-10 Collegium Pharmaceutical, Inc. Nuo piktnaudžiavimo apsaugotos vaistų formos
DE102004045037A1 (de) * 2004-09-15 2006-03-16 Basf Ag Pharmazeutische Darreichungsformen mit erschwerter Extrahierbarkeit eines Sympathomimetikums aus der Darreichungsform
US9238073B2 (en) 2006-04-12 2016-01-19 Wyeth Llc Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
WO2008150526A1 (en) * 2007-06-04 2008-12-11 Shear/Kershman Laboratories, Inc. Tamper resistant lipid-based oral dosage form for opioid agonists
US8901113B2 (en) 2009-09-30 2014-12-02 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CA2822790C (en) 2010-12-22 2018-11-20 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
JP5638151B2 (ja) 2010-12-23 2014-12-10 パーデュー、ファーマ、リミテッド、パートナーシップ 不正加工抵抗性の(tamperresistant)固形経口剤形
US20150238615A1 (en) * 2011-12-12 2015-08-27 Leonard Mackles Denaturants for sympathomimetic amines
CN104968333B (zh) 2012-11-30 2018-07-10 阿库拉制药公司 活性药物成分的自调节释放
EP2953618B1 (en) 2013-02-05 2020-11-11 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
WO2015145461A1 (en) 2014-03-26 2015-10-01 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
US10058490B2 (en) * 2014-12-24 2018-08-28 L'oreal Acoustically-activated cosmetic hydrogels
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
CN114073689B (zh) * 2020-08-10 2024-01-12 江苏长泰药业有限公司 一种防提取药物组合物及其制剂
CN114073690B (zh) * 2020-08-10 2024-01-12 江苏长泰药业有限公司 一种含有氨基酸的防提取药物组合物及其制剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3169092A (en) * 1963-09-26 1965-02-09 Richardson Merrell Inc Stabilization of amines by tartrazine and bisulfite
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
GB1593261A (en) * 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
US4493827A (en) * 1983-11-14 1985-01-15 Ronald Valle Method of inducing sleep
US4601894A (en) * 1985-03-29 1986-07-22 Schering Corporation Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
US4657757A (en) * 1985-03-29 1987-04-14 Schering Corporation Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
US4689223A (en) * 1986-04-24 1987-08-25 T & R Chemicals, Inc. Method of treating the symptoms of the common cold
ZA904021B (en) * 1989-11-24 1991-02-27 Van Der Linde Leon Slimming preparations
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
DK0701434T3 (da) * 1993-06-04 2002-11-18 Warner Lambert Co Præparater indeholdende siliciumdioxid til forbedring af deres smag
AUPM814994A0 (en) * 1994-09-14 1994-10-06 Sterling Winthrop Inc. Codeine-containing formulations
US5585108A (en) * 1994-12-30 1996-12-17 Nanosystems L.L.C. Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays

Also Published As

Publication number Publication date
AR006571A1 (es) 1999-09-08
MX9807594A (en) 1999-03-31
DK0894010T3 (da) 2003-10-27
CA2250010A1 (en) 1997-10-16
AU711752B2 (en) 1999-10-21
ES2202605T3 (es) 2004-04-01
ATE244019T1 (de) 2003-07-15
US6136864A (en) 2000-10-24
TW522012B (en) 2003-03-01
EP0894010A2 (en) 1999-02-03
DE69723248D1 (de) 2003-08-07
WO1997037689A3 (en) 1997-12-04
DE69723248T2 (de) 2004-05-27
UY24512A1 (es) 2001-08-27
NZ332233A (en) 1999-11-29
WO1997037689A2 (en) 1997-10-16
SI0894010T1 (en) 2003-10-31
CA2250010C (en) 2008-06-10
AU2436097A (en) 1997-10-29
PE20011304A1 (es) 2002-01-18
EP0894010B1 (en) 2003-07-02
JP2001527514A (ja) 2001-12-25
BR9708559A (pt) 1999-08-03

Similar Documents

Publication Publication Date Title
PT894010E (pt) Desnaturantes para sais de amina simpaticomimetica
PT1080275E (pt) Turfa para relva sintetica
DK0818448T3 (da) Cycloalkanopyridiner som CETP-inhibitorer
DE69822505D1 (de) Neue metformin salze und verfahren
BR9710466A (pt) Modifica-Æo de polipropileno por amina de poliester
HK1039898A1 (zh) 含有擬交感神經胺鹽的不適合非法使用的組合物
PT1113965E (pt) Acessorio para gargalo de garrafa
NO20002808L (no) Fjærkraftklemme
BR9505851A (pt) Máquina de etiquetar,para objetos
ID27766A (id) Garam-garam paroksetin
DE69718778D1 (de) Aminierungsprozess
BR9707518A (pt) Sais de derivados de imidazolina
ES1036416Y (es) Cabeza de manguito perfeccionada para conexionado de canalizaciones.
BR1101025A (pt) Sais estáveis de sulfo-adenosil-l-metionina (same) especialmente adequados para emprego parenteral
ZA973020B (en) Denaturants for sympathomimetic amine salts.
ES1038363Y (es) Protector perfeccionado para cabezal de cepillos dentales.
BR7401298U (pt) Suporte para gravata
BR7400259U (pt) Suporte para gravatas
ES1028007Y (es) Bloque perfeccionado para construccion.
ES1038965Y (es) Cabezal para mocho de fregona.
ES1036500Y (es) Nuevo cepillo para la cabeza
DE59812122D1 (de) Emulgatoren für aminoharze
GB9808236D0 (en) Amide amine salts
ES1027889Y (es) Sujecion para plastificados.
BR9704453A (pt) Suporte para pincéis